Cargando…
Trends and Limitations in the Assessment of the Contractile Properties of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Patients With Dilated Cardiomyopathy
The application of human induced pluripotent stem cell-derived cardiomyocytes (hiPSCMs) from patients is expected in disease modeling and drug screening in vitro. Dilated cardiomyopathy (DCM) is an intractable disease characterized by the impairment of systolic function and leads to severe heart fai...
Autores principales: | Ito, Masamichi, Nomura, Seitaro, Morita, Hiroyuki, Komuro, Issei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494730/ https://www.ncbi.nlm.nih.gov/pubmed/33102534 http://dx.doi.org/10.3389/fcvm.2020.00154 |
Ejemplares similares
-
Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023) -
Development of a Contractile Cardiac Fiber From Pluripotent Stem Cell Derived Cardiomyocytes
por: Hansen, Katrina J., et al.
Publicado: (2018) -
Identification of MYLK3 mutations in familial dilated cardiomyopathy
por: Tobita, Takashige, et al.
Publicado: (2017) -
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022) -
Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports
por: Kawamura, Takuji, et al.
Publicado: (2023)